Fifteen-Year Immunologic Follow-Up of Women Who Received One, Two and Three Doses of the Bivalent HPV Vaccine in the Costa Rica HPV-16/18 Vaccine Trial (CVT) the CVT EXTEND Study
Conditions: Human Papillomavirus; Cervical Cancer Intervention: Sponsor: National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Allergy & Immunology | Cancer | Cancer & Oncology | Cancer Vaccines | Costa Rica Health | Study | Vaccines | Women